Inventor · disambiguated record
Xiang Fang
Also filed as: FANG XIANG · FANG XIANG-MING
8 granted patents·5 pending applications·21 citations·filing 2004–2025
80Inventor score
Files withNEWRON PHARM SPA2UNIV TEXAS2WUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD2BEIJING XINNA INTERNATIONAL NEW MATERIALS TECH CO LTD1DEISSEROTH ALBERT1
Top patents by PatentIndex Score
13 records- 0183US9353167B2Methods for generating immunity to antigenMICROVAX LLC·Filed 2014·Granted May 31, 2016·3 cites·5 claims
- 0283US8828957B2Methods for generating immunity to antigenDEISSEROTH ALBERT·Filed 2004·Granted Sep 9, 2014·14 cites·47 claims
- 0379US10611757B2Crystalline form of chemical compound, and preparation method, composition, and application thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2017·Granted Apr 7, 2020·2 cites·20 claims
- 0476US11008311B2Potassium salt of benzimidazole compound and preparation method therefor, composition and application thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2017·Granted May 18, 2021·2 cites·12 claims
- 0565US2025257031A1Process for the production of substituted 2-[2-(phenyl)ethylamino]alkaneamide derivativesNEWRON PHARM SPA·Filed 2025·Application pending·0 cites
- 0661US2025347684A1Metabolic biomarkers in blood serum for diagnosis of alzheimer's diseaseUNIV TEXAS·Filed 2025·Application pending·0 cites
- 0756US12183924B2Metal organic framework-derived carbon aerogel, preparation method thereof and application in lithium ion batteriesSOOCHOW MOFS SCIENCE AND TECH LTD·Filed 2024·Granted Dec 31, 2024·0 cites·6 claims
- 0855US12291495B2Process for the production of substituted 2-[2-(phenyl)ethylamino] alkaneamide derivativesNEWRON PHARM SPA·Filed 2020·Granted May 6, 2025·0 cites·20 claims
- 0955US2023333099A1Composite magnetic nanomaterial based on dna tetrahedron, preparation therefor and use thereofNAT INST METROLOGY CHINA·Filed 2023·Application pending·0 cites
- 1051US2022195508A1tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's DiseaseUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1148US12275692B2Method for preparing sodium taurate as taurine intermediate, and method for preparing taurineZHEJIANG NHU CO LTD·Filed 2020·Granted Apr 15, 2025·0 cites·8 claims
- 1242US10233439B2Directed modification of glucosamine synthase mutant and application thereofYANGZHOU RIXING BIO TECH CO LTD·Filed 2017·Granted Mar 19, 2019·0 cites·3 claims
- 1327US2020305374A1Method for inducing active response of plantsBEIJING XINNA INTERNATIONAL NEW MATERIALS TECH CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiang Fang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →